These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9232762)

  • 1. Tutorial in biostatistics Bayesian data monitoring in clinical trials.
    Fayers PM; Ashby D; Parmar MK
    Stat Med; 1997 Jun; 16(12):1413-30. PubMed ID: 9232762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The what, why and how of Bayesian clinical trials monitoring.
    Freedman LS; Spiegelhalter DJ; Parmar MK
    Stat Med; 1994 Jul 15-30; 13(13-14):1371-83; discussion 1385-9. PubMed ID: 7973217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where's the utility in Bayesian data-monitoring of clinical trials?
    Ashby D; Tan SB
    Clin Trials; 2005; 2(3):197-205; discussion 205-8. PubMed ID: 16279143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian approach in design and analysis of pediatric cancer clinical trials.
    Ye J; Reaman G; De Claro RA; Sridhara R
    Pharm Stat; 2020 Nov; 19(6):814-826. PubMed ID: 32537913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritis.
    Smith CL; Jin Y; Raddad E; McNearney TA; Ni X; Monteith D; Brown R; Deeg MA; Schnitzer T
    Pharm Stat; 2019 Jan; 18(1):39-53. PubMed ID: 30321909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Bayesian methods for monitoring clinical trials.
    Greenhouse JB; Wasserman L
    Stat Med; 1995 Jun; 14(12):1379-91. PubMed ID: 7569495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data augmentation priors for Bayesian and semi-Bayes analyses of conditional-logistic and proportional-hazards regression.
    Greenland S; Christensen R
    Stat Med; 2001 Aug; 20(16):2421-8. PubMed ID: 11512132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Bayesian Methods to Augment the Interpretation of Critical Care Trials. An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial.
    Zampieri FG; Casey JD; Shankar-Hari M; Harrell FE; Harhay MO
    Am J Respir Crit Care Med; 2021 Mar; 203(5):543-552. PubMed ID: 33270526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unified method for monitoring and analysing controlled trials.
    Grossman J; Parmar MK; Spiegelhalter DJ; Freedman LS
    Stat Med; 1994 Sep; 13(18):1815-26. PubMed ID: 7997715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size reestimation by Bayesian prediction.
    Wang MD
    Biom J; 2007 Jun; 49(3):365-77. PubMed ID: 17623342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of Bayesian monitoring methods in deciding whether and when to stop a clinical trial: an example of a neonatal cooling trial.
    Pedroza C; Tyson JE; Das A; Laptook A; Bell EF; Shankaran S;
    Trials; 2016 Jul; 17(1):335. PubMed ID: 27450203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian predictive approach for inference about proportions.
    Lecoutre B; Derzko G; Grouin JM
    Stat Med; 1995 May 15-30; 14(9-10):1057-63; discussion 1064. PubMed ID: 7569500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian estimation of cost-effectiveness from censored data.
    Heitjan DF; Kim CY; Li H
    Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Bayesian statistics to decision making during a clinical trial.
    Freedman LS; Spiegelhalter DJ
    Stat Med; 1992 Jan; 11(1):23-35. PubMed ID: 1557573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim analysis in clinical trials.
    Armitage P
    Stat Med; 1991 Jun; 10(6):925-35; discussion 936-7. PubMed ID: 1876782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On some applications of Bayesian methods in cancer clinical trials.
    Greenhouse JB
    Stat Med; 1992 Jan; 11(1):37-53. PubMed ID: 1557574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential monitoring of clinical trials with multiple survival endpoints.
    Williams PL
    Stat Med; 1996 Nov 15-30; 15(21-22):2341-57; discussion 2367-70. PubMed ID: 8931205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer.
    George SL; Li C; Berry DA; Green MR
    Stat Med; 1994 Jul 15-30; 13(13-14):1313-27. PubMed ID: 7973212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.